Insider: Poulton Stuart EVP, Chief Development Officer - Karyopharm Therapeutics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 27,710 | 0 | 27,710 |
| Value | $181,500.50 | $0.00 | $181,500.50 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/15/2025 | DDS | 401 | Direct | COM | $6.43 | $2,578.43 | 27,710 |
| 07/29/2025 | DDS | 191 | Direct | COM | $4.37 | $834.67 | 27,223 |
| 03/04/2025 | DDS | 3,548 | Direct | COM | $6.29 | $22,316.92 | 27,414 |
| 02/18/2025 | DDS | 5,914 | Direct | COM | $0.63 | $3,725.82 | 320,714 |
| 07/30/2024 | DDS | 2,883 | Direct | COM | $1.06 | $3,055.98 | 326,628 |
| 03/01/2024 | DDS | 6,155 | Direct | COM | $1.20 | $7,386.00 | 329,511 |
| 02/29/2024 | DDS | 16,311 | Direct | COM | $1.17 | $19,083.87 | 335,666 |
| 02/15/2024 | DDS | 5,748 | Direct | COM | $1.33 | $7,644.84 | 163,871 |
| 02/15/2024 | DDS | 99 | Direct | COM | $1.40 | $138.60 | 163,772 |
| 07/28/2023 | DDS | 2,845 | Direct | COM | $1.70 | $4,836.50 | 156,286 |
| 02/15/2023 | DDS | 5,665 | Direct | COM | $3.19 | $18,071.35 | 64,335 |
| 02/15/2023 | DDS | 8 | Direct | COM | $3.23 | $25.84 | 64,327 |
| 02/15/2023 | DDS | 196 | Direct | COM | $3.16 | $619.36 | 64,131 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research